SCHEMBL2642985

SCHEMBL2642985

Cc1csc([S])n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2487462 0.71
SCHEMBL128316 0.71
SCHEMBL18157874 0.71 SMN1; SMN2 (0.55)
Iodide SCHEMBL27887241 0.69
SCHEMBL105797 0.69
Bromide SCHEMBL27485582 0.69
Hydrochloric Acid SCHEMBL11308925 0.69
SCHEMBL14127359 0.69
SCHEMBL9664818 0.67
SCHEMBL2642951 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4034090-A ANTIBACTERIAL RHONE-POULENC INDUSTRIES (FR) 1977-07-05 US claimed
US-8765789-B2 2-pyridinecarboxamide derivatives MSD K.K. (JP) 2014-07-01 US disclosed
US-20130085156-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES MSD K.K. (JP) 2013-04-04 US disclosed
US-8344003-B2 2-pyridinecarboxamide derivatives MSD K. K. (JP) 2013-01-01 US disclosed
US-20100041660-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES MSD K.K. (JP) 2010-02-18 US disclosed
US-7629362-B2 2-pyridine carboxamide derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2009-12-08 US disclosed
US-7199139-B2 Medicinal compositions containing diuretic and insulin resistance-improving agent SANKYO COMPANY, LIMITED (JP) 2007-04-03 US disclosed
US-20060258701-A1 Novel 2-pyridinecarboxamide derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-11-16 US disclosed
EP-1354602-B1 MEDICINAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE-IMPROVING AGENT SANKYO CO (JP) 2006-10-04 EP disclosed
EP-1695716-A2 Medicinal compositions containing diuretics and insulin sensitizers Sankyo Company, Limited (JP) 2006-08-30 EP disclosed
US-20020137664-A1 Substituted piperidines as melanocortin-4 receptor agonists MERCK & CO., INC. 2002-09-26 US disclosed
EP-1187614-A1 SUBSTITUTED PIPERIDINES AS MELANOCORTIN-4 RECEPTOR AGONISTS Merck & Co., Inc. (US) 2002-03-20 EP disclosed
US-6350760-B1 OBESITY, DIABETES, SEXUAL DYSFUNCTION; MERCK & CO., INC. 2002-02-26 US disclosed
EP-1167357-A1 ALPHA-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES Sankyo Company, Limited (JP) 2002-01-02 EP disclosed
WO-2000074679-A1 SUBSTITUTED PIPERIDINES AS MELANOCORTIN-4 RECEPTOR AGONISTS MERCK & CO., INC. (US) 2000-12-14 WO disclosed
US-4914206-A ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-04-03 US disclosed
EP-0226896-A2 Lankacidin derivatives and production thereof Takeda Chemical Industries, Ltd. (JP) 1987-07-01 EP disclosed
EP-0069373-A1 (5R, 6R)-Penem compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1983-01-12 EP disclosed
US-4034090-A ANTIBACTERIAL RHONE-POULENC INDUSTRIES (FR) 1977-07-05 US disclosed
US-4034090-A ANTIBACTERIAL RHONE-POULENC INDUSTRIES (FR) 1977-07-05 US disclosed